Chemical and Biological properties
DEAE-Dextran offers a wide range of chemical and biological properties. The following properties are well documented:
① Adjuvant in vaccines
② Agent for transfection
③ Stabilizer of proteins
④ Agent for reduction of cholesterol count
⑤ Enhancer of viral infectivity
Uses
DEAE-Dextran is used in the development of sustained release protein delivery and nucleic acid transfection systems. The use of DEAE-Dextran as an efficient adjuvant in vaccine production is well established. For instance, DEAE-Dextran has been used for immunization of guinea pigs and swine with inactivated foot-and-mouth disease and rhesus monkeys with inactivated Venezulean equine encephalomyelitis virus, IVEE. The mechanism of action of DEAE-Dextran is not clear. The effect on the humoral response of rhesus monkeys to IVEE vaccine results in a typical IgM-IgG response. It has been speculated that DEAE-Dextran may cause a stimulation of the helper T-cell function in antibody synthesis.
Dextran derivatives
DEAE-Dextran, being a polycation, offers many applications, such as a component/adjuvant in vaccines, for transfection and gene therapy, cholesterol/weight modulation, a stabiliser of proteins, in drug delivery and as a flocculant.
DEAE-Dextran is made by reaction of dextran with (2-chloroethyl) diethylammoniumchlorid in alkaline solution.

DEAE - Dextran contains three basic groups with different pKa values. There are two tertiary groups, one in the single substituted glucose unit having a pKa value of approximately 9.2 and the tertiary group in the tandem substitution having a pKa value of approximately 5.5. The quaternary amino group in the tandem substitution has a pKa value ~ 14.
Like the polyanions, the polycations also exhibit a wide range of interesting biological properties. In particular, DEAE-dextrans appear to enhance a number of cellular processes. Many reports (398-401) testify to the enhancement of cellular uptake of viral RNA and also intact virus particles. Considerable interest has been focussed on the enhanced production of interferon by polyribonucleotide complexes in the presence of DEAE-dextran (402–404). These processes appear to operate without detrimental effects on the viability of the cells (398). To what extent these effects are due to the interaction between the cell surface (net negative charge) and the polycation is uncertain. For most of these studies, a DEAE-dextran with MW approx. 500 000 and DS 0.5 has been used at concentrations from 10–500 µg/ml.
DEAE-Dextran 500 is a polycationic derivative of dextran, produced from dextran with an average molecular weight >500,000 Da. DEAE-Dextran 500 has a broad variety of applications including medicinal products, technical and chromatographic applications and as a polycationic stabilizing molecule.
DEAE-Dextran 500 is supplied in its HCI form.